Analysis of outer membrane permeability of Pseudomonas aeruginosa and bactericidal activity of endolysins KZ144 and EL188 under high hydrostatic pressure
- PMID: 18248421
- DOI: 10.1111/j.1574-6968.2007.01051.x
Analysis of outer membrane permeability of Pseudomonas aeruginosa and bactericidal activity of endolysins KZ144 and EL188 under high hydrostatic pressure
Abstract
The parameters influencing outer membrane permeability of Pseudomonas aeruginosa PAO1 under high hydrostatic pressure were quantified and optimized, using fusion between a specific A1gamma peptidoglycan-binding domain and green fluorescent protein (PBD-GFP). Based on the obtained data, optimal conditions were defined to assess the synergistic bactericidal action between high hydrostatic pressure and peptidoglycan hydrolysis by bacteriophage-encoded endolysins KZ144 and EL188. Under high hydrostatic pressure, both endolysins show similar inactivation of P. aeruginosa as the commonly used hen egg white lysozyme or slightly higher inactivation in the case of EL188 at 150 and 200 MPa. The partial contribution of pressure to the bacterial inactivation increases with higher pressure, while the partial contribution of the enzymes is maximal at the onset pressure of outer membrane permeabilization for the PBD-GFP protein (175 MPa). This study's results demonstrate the usefulness of this approach to determine optimal synergy for hurdle technology applications.
Similar articles
-
Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL.Mol Microbiol. 2007 Sep;65(5):1334-44. doi: 10.1111/j.1365-2958.2007.05870.x. Mol Microbiol. 2007. PMID: 17697255
-
The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144.Biochem Biophys Res Commun. 2009 May 29;383(2):187-91. doi: 10.1016/j.bbrc.2009.03.161. Epub 2009 Apr 5. Biochem Biophys Res Commun. 2009. PMID: 19348786
-
Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa.J Appl Microbiol. 2011 Mar;110(3):778-85. doi: 10.1111/j.1365-2672.2010.04931.x. Epub 2011 Jan 17. J Appl Microbiol. 2011. PMID: 21241420
-
Bacteriophage endolysins--current state of research and applications.Curr Opin Microbiol. 2005 Aug;8(4):480-7. doi: 10.1016/j.mib.2005.06.002. Curr Opin Microbiol. 2005. PMID: 15979390 Review.
-
Taking aim on bacterial pathogens: from phage therapy to enzybiotics.Curr Opin Microbiol. 2007 Oct;10(5):461-72. doi: 10.1016/j.mib.2007.08.002. Epub 2007 Sep 27. Curr Opin Microbiol. 2007. PMID: 17904412 Review.
Cited by
-
Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens.Front Microbiol. 2023 Sep 8;14:1170418. doi: 10.3389/fmicb.2023.1170418. eCollection 2023. Front Microbiol. 2023. PMID: 37789862 Free PMC article. Review.
-
Characterization of a lytic Pseudomonas aeruginosa phage vB_PaeP_ASP23 and functional analysis of its lysin LysASP and holin HolASP.Front Microbiol. 2023 Mar 15;14:1093668. doi: 10.3389/fmicb.2023.1093668. eCollection 2023. Front Microbiol. 2023. PMID: 36998407 Free PMC article.
-
Cecropin A Improves the Antibacterial Activity of Hen Egg White Lysozyme against Challenging Salmonella enterica Serovars.Pharmaceutics. 2022 Oct 16;14(10):2201. doi: 10.3390/pharmaceutics14102201. Pharmaceutics. 2022. PMID: 36297635 Free PMC article.
-
Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance.Front Microbiol. 2022 Mar 3;13:841905. doi: 10.3389/fmicb.2022.841905. eCollection 2022. Front Microbiol. 2022. PMID: 35308352 Free PMC article. Review.
-
Enzybiotics: Enzyme-Based Antibacterials as Therapeutics.Adv Exp Med Biol. 2019;1148:233-253. doi: 10.1007/978-981-13-7709-9_11. Adv Exp Med Biol. 2019. PMID: 31482502 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

